We’re pleased to announce that Cure EB is joining three other EB charities to fund the clinical development of a new anti-fibrotic drug called TXA127.
Scientists at the Sidney Kimmel Cancer Center at Jefferson University have discovered the cause of aggressive skin cancers in Recessive Dystrophic Epidermolysis Bullosa (RDEB)
Click to see report from Jefferson University
(source: www.raredr.com, May 10th 2018)
(source: eurekaalert.org, April 12th 2018)